Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Global | Publication | August 2018
The government published a long-heralded draft Registration of Overseas Entities Bill on July 23, 2018.
The purpose of the Bill is to “prevent and combat the use of land in the UK for money laundering purposes by increasing the transparency of beneficial ownership information relating to overseas entities that own land in the UK”. It seeks to achieve this by establishing a new register of the beneficial owners and controllers of such entities – the first of its kind. The new register will be held by Companies House and the current intention is that it will go live by 2021.
In broad terms the Bill provides that
Comments on the draft Bill are invited by September 17, 2018 but it is unlikely that the fundamentals will change. Overseas entities need to be aware that compliance may be onerous, not to say time-consuming, particularly for those with sophisticated ownership structures. There will also be additional levels of due diligence for those proposing to enter into a land transaction with an overseas entity.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025